Kingfa Science

What does Kingfa Science do?

Kingfa Science & Technology (India) Ltd is a small-cap company in the plastic products industry, reporting net sales of ₹470 Cr and a net profit of ₹42 Cr for Q1 2025. The company, formerly Hydro S&S Industries, has a market cap of ₹3,907 Cr and key metrics include a P/E of 26.00 and a dividend yield of 0.31%.

Overview:<BR>Kingfa Science & Technology (India) Ltd operates in the plastic products industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in November 1983 as Hydro S&S Industries Limited and was renamed to Kingfa Science & Technology (India) Limited in December 2015. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 470 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 42 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 3,907 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 26.00<BR>- Industry P/E: 41<BR>- Dividend Yield: 0.31%<BR>- Debt-Equity: 0.03<BR>- Return on Equity: 20.98%<BR>- Price to Book: 5.45<BR><BR>Contact Details:<BR>Address: Dhun Building III Floor, 827 Anna Salai Chennai Tamil Nadu : 600002<BR>Tel: 91-44-28521736 (4 lines)<BR>Email: cs@kingfaindia.com<BR>Website: http://www.hssil.com

Has Kingfa Science declared dividend?

Yes, Kingfa Science & Technology (India) Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of September 17, 2024. The company has shown strong long-term performance, with a total return of 626.88% over the last 5 years.

Kingfa Science & Technology (India) Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 17 Sep 24<BR><BR>Dividend Yield: 0.31%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -2.21%, with a dividend return of 0%, resulting in a total return of -2.21%.<BR><BR>Over the 1-year period, the price return was 65.65%, the dividend return was 0.53%, leading to a total return of 66.18%.<BR><BR>For the 2-year period, the price return was 60.17%, with a dividend return of 0.51%, culminating in a total return of 60.68%.<BR><BR>In the 3-year span, the price return reached 238.32%, while the dividend return was 1.28%, resulting in a total return of 239.6%.<BR><BR>During the 4-year period, the price return was 202.84%, with a dividend return of 1.00%, leading to a total return of 203.84%.<BR><BR>Over the last 5 years, the price return was 624.41%, and the dividend return was 2.47%, resulting in a total return of 626.88%.<BR><BR>Overall, Kingfa Science has declared a significant dividend, and while the recent returns show some volatility, the long-term performance appears strong, particularly over the 5-year period.

Who are the peers of the Kingfa Science?

Kingfa Science's peers include Supreme Inds., Astral, Finolex Inds., Garware Hi Tech, Shaily Engineer, Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes. Kingfa Science has average management risk and growth, with a 1-year return of 74.77%, while peers show varying management risks and returns.

Peers: The peers of Kingfa Science are Supreme Inds., Astral, Finolex Inds., Garware Hi Tech, Shaily Engineer., Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes.<BR><BR>Quality Snapshot: Excellent management risk is observed at Supreme Inds. and the rest. Good management risk is found at Astral, Finolex Inds., Shaily Engineer., Prince Pipes, and Apollo Pipes, while Average management risk is present at Garware Hi Tech, Kingfa Science, and Prakash Pipes. Below Average management risk is noted for Jain Irrigation and Jai Corp. Growth is Average at Garware Hi Tech, while Good growth is seen at Astral, Shaily Engineer., Kingfa Science, Jain Irrigation, and the rest. Below Average growth is found at Finolex Inds. and Prince Pipes, while Jai Corp has Below Average growth. Excellent capital structure is noted at Supreme Inds., Finolex Inds., Garware Hi Tech, Kingfa Science, and the rest, while Good capital structure is seen at Shaily Engineer. Below Average capital structure is present at Jain Irrigation and Jai Corp.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Shaily Engineer. at 199.86%, while the lowest is Finolex Inds. at -34.87%. Kingfa Science's 1-year return of 74.77% is significantly higher than that of Finolex Inds. Negative six-month returns are noted for Supreme Inds., Astral, Finolex Inds., Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes.

Who are in the management team of Kingfa Science?

As of March 2023, the management team of Kingfa Science includes Bo Jingen, D Balaji, Wu Xiaohui (executive directors), and independent directors Narayanaswamy Subramanian, Dilip Dinkar Kulkarni, and Nilima Ramrao Shinde. Their remuneration ranges from 3.2 to 89.03 lacs INR.

As of March 2023, the management team of Kingfa Science includes the following members:<BR><BR>1. Bo Jingen - Non Independent Executive Director, with a remuneration of 26.91 lacs INR.<BR>2. D Balaji - Executive Non Independent Director, with a remuneration of 89.03 lacs INR.<BR>3. NARAYANASWAMY SUBRAMANIAN - Independent Non Executive Director, with a remuneration of 7.2 lacs INR.<BR>4. Dilip Dinkar Kulkarni - Independent Non Executive Director, with a remuneration of 7.8 lacs INR.<BR>5. Nilima Ramrao Shinde - Independent Non Executive Director, with a remuneration of 7.8 lacs INR.<BR>6. Wu Xiaohui - Non Independent Executive Director, with a remuneration of 3.2 lacs INR. <BR><BR>This team comprises both executive and independent directors, contributing to the governance and strategic direction of the company.

Who are the top shareholders of the Kingfa Science?

The top shareholders of Kingfa Science include Kingfa Sci. & Tech. Co. Ltd. with 74.99%, Hongkong Victory Investment Co Limited at 6.32%, and Foreign Institutional Investors holding 6.35%. Individual investors collectively own 15.31%, while mutual funds have a minimal stake of 0.04%.

The top shareholders of Kingfa Science include the following:<BR><BR>1. **Kingfa Sci. & Tech. Co. Ltd.** - This entity holds the largest share, with a significant 74.99% stake in the company.<BR>2. **Hongkong Victory Investment Co Limited** - This is the highest public shareholder, owning 6.32% of the shares.<BR>3. **Foreign Institutional Investors (FIIs)** - A total of 6 FIIs collectively hold 6.35%.<BR>4. **Mutual Funds** - There is minimal representation from mutual funds, with just 0.04% held by one scheme.<BR>5. **Individual Investors** - They hold a combined 15.31% of the shares.<BR><BR>Overall, the majority ownership is concentrated with the promoters, particularly Kingfa Sci. & Tech. Co. Ltd.

When is the next results date for Kingfa Science?

The next results date for Kingfa Science is July 30, 2025.

The next results date for Kingfa Science is scheduled for July 30, 2025.

How big is Kingfa Science?

As of 24th July, Kingfa Science & Technology (India) Ltd has a market capitalization of 4,439.00 Cr, with recent net sales of 1,744.69 Cr and a net profit of 152.86 Cr. Shareholder's funds are 588.58 Cr, and total assets are valued at 994.44 Cr.

As of 24th July, Kingfa Science & Technology (India) Ltd has a market capitalization of 4,439.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 1,744.69 Cr and a Net Profit of 152.86 Cr.<BR><BR>For the latest annual period ending March 2024, the Shareholder's Funds amounted to 588.58 Cr, while the Total Assets were valued at 994.44 Cr.

Is Kingfa Science technically bullish or bearish?

As of November 3, 2025, Kingfa Science's trend is mildly bullish, supported by a bullish MACD and moving averages, though tempered by a mildly bearish KST and Dow Theory indicators.

As of 3 November 2025, the technical trend for Kingfa Science has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on both weekly and monthly time frames, along with bullish daily moving averages. However, the KST indicates a mildly bearish monthly trend, and Dow Theory shows a mildly bearish weekly stance, which tempers the overall bullish outlook. The Bollinger Bands are also mildly bullish on both weekly and monthly charts. Despite recent price fluctuations, the stock has shown strong returns over various periods, particularly in the long term.

How has been the historical performance of Kingfa Science?

Kingfa Science has shown consistent growth, with net sales increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25, and significant improvements in profitability, total assets, and cash flow. Key metrics like profit after tax rose from 5.32 Cr to 152.86 Cr during the same period, reflecting strong operational efficiency.

Answer:<BR>The historical performance of Kingfa Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Kingfa Science has demonstrated significant growth in net sales, increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25. This upward trend is mirrored in total operating income, which rose from 741.50 Cr in Mar'20 to 1,744.69 Cr in Mar'25. The company's operating profit (PBDIT) also saw a substantial increase, reaching 234.45 Cr in Mar'25, up from just 25.96 Cr in Mar'21. Profit before tax followed suit, climbing to 206.08 Cr in Mar'25 from 11.85 Cr in Mar'21, while profit after tax reached 152.86 Cr in Mar'25, a significant rise from 5.32 Cr in Mar'21. The company's total assets grew from 596.30 Cr in Mar'20 to 1,155.62 Cr in Mar'25, reflecting a robust expansion in its financial base. Additionally, the book value per share has increased from 287.84 in Mar'20 to 601.63 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities improved markedly, reaching 59.00 Cr in Mar'25, compared to a negative cash flow in Mar'21. Overall, Kingfa Science's financial performance illustrates a strong upward trend across key metrics, highlighting its growth and operational efficiency.

Is Kingfa Science overvalued or undervalued?

As of December 3, 2025, Kingfa Science is fairly valued with a PE ratio of 34.86, lower than some peers like Supreme Industries and Astral, but higher than Finolex Industries, and has delivered a strong 200% return over three years compared to the Sensex's 35.37%.

As of 3 December 2025, Kingfa Science has moved from an expensive to a fair valuation grade. The company appears to be fairly valued at this time. Key ratios include a PE ratio of 34.86, an EV to EBITDA of 23.91, and a ROE of 21.61%. <BR><BR>In comparison to peers, Kingfa Science's PE ratio is lower than Supreme Industries at 49.49 and Astral at 74.25, both of which are classified as expensive. Additionally, Finolex Industries, which is also rated fair, has a significantly lower PE ratio of 22.26, indicating that Kingfa Science is relatively more expensive than some of its peers. Despite a recent decline in stock price, Kingfa Science has shown strong long-term performance, with a 3-year return of 200% compared to the Sensex's 35.37%.

Should I buy, sell or hold Kingfa Science & Technology (India) Ltd?

Why is Kingfa Science & Technology (India) Ltd falling/rising?

As of 07-Feb, Kingfa Science & Technology (India) Ltd is experiencing a stock price decline to 4,256.40, down -4.66%. This drop is due to negative market sentiment, underperformance compared to its sector, and reduced investor participation following a trend reversal after previous gains.

As of 07-Feb, Kingfa Science & Technology (India) Ltd is experiencing a decline in its stock price, currently at 4,256.40, reflecting a change of -208.25 (-4.66%). This drop can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has underperformed compared to its sector, with a performance today that is down by -3.39%. Additionally, it opened with a significant loss of -2.45% and reached an intraday low of Rs 4210, marking a decrease of -5.7%. This indicates a negative market sentiment surrounding the stock.<BR><BR>Moreover, the stock has recently experienced a trend reversal, falling after four consecutive days of gains, which may have contributed to investor caution. The trading volume has also shown a decline, with delivery volume on 05 February falling by -9.7% against the 5-day average, suggesting reduced investor participation.<BR><BR>While the company has a low debt-to-equity ratio and has shown healthy long-term growth in net sales and operating profit, these positive factors are currently overshadowed by the recent price movements and market performance. The stock's performance over the past week and month has been negative, with declines of -1.62% and -2.91%, respectively, while the benchmark Sensex has shown positive returns during the same periods. <BR><BR>In summary, the combination of negative market sentiment, recent price declines, and reduced investor participation are key reasons for the falling stock price of Kingfa Science & Technology (India) Ltd.

Which are the latest news on Kingfa Science?

Are Kingfa Science & Technology (India) Ltd latest results good or bad?

Kingfa Science & Technology (India) Ltd's latest Q3 FY26 results are generally positive, with a net profit increase of 9.80% quarter-on-quarter and 30.44% year-on-year, alongside record revenue of ₹489.46 crores. However, a slight decline in operating margin to 12.64% raises concerns about rising costs and competitive pressures.

Kingfa Science & Technology (India) Ltd's latest results for Q3 FY26 present a mixed but generally positive picture. The company reported a net profit of ₹45.17 crores, which is a significant increase of 9.80% quarter-on-quarter and a robust 30.44% year-on-year. This indicates strong profitability growth and reflects well on the company's operational performance.<BR><BR>Revenue also saw a healthy increase, reaching ₹489.46 crores, up 5.10% from the previous quarter and 11.15% year-on-year. This marks the highest quarterly revenue in the company's history and demonstrates sustained demand in its industrial plastics portfolio.<BR><BR>However, there are concerns regarding the operating margin, which decreased to 12.64% from 13.01% in the previous quarter. While this is still an improvement from 11.66% a year ago, the sequential decline suggests that the company may be facing rising input costs or competitive pricing pressures that could impact future profitability.<BR><BR>Overall, while the growth in net profit and revenue is encouraging, the margin compression warrants close attention. Investors should keep an eye on how the company manages these challenges in the upcoming quarters.